News | February 16, 2022
Clean Science and Technology to invest Rs. 300 - 500 Cr on expansion
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
The funds will be used to expand digital product offerings, grow their online customer base, and launch their flagship clinic in Bengaluru
BDR Pharmaceuticals is a home-grown company with operations in India and overseas. It’s known for its formulations portfolio and has a presence in specialty medicines. The company has ambitious plans as it has ramped up capacity and looking to foray into regulated markets. Raheel Shah, Director, BDR Group of Companies shares his insights in an interview with Thomas C Thottathil, Editor, Indian Pharma Post
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
Expected to open later this year, the facility will significantly increase distribution capacity to meet the growing demand for production materials by Ireland's biopharma industry
FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants
In the first phase of the Grangemouth site expansion, two new ADC manufacturing suites, operational by Q3 2023, will be added to the existing three
Wockhardt has entered into an agreement with Russian Direct Investment Fund and Enso Healthcare to manufacture and supply Sputnik V and Sputnik Light vaccines against Covid-19
Aster DM Healthcare has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
